At yesterday’s lab journal club, with
@yeganeh-almasi.bsky.social, we discussed PMC10848161: A case study showing γδ T cells driving lasting anti-tumor immunity during PD-1 blockade in Merkel cell carcinoma.
@natcomms.nature.com
#Immunotherapy #γδTcells
www.nature.com/articles/s41...
Immune checkpoint blockade cancer therapy has been designed to enable tumor killing by conventional αβ T cells. Here authors show that in a Merkel cell carcinoma patient showing complete response to a...
